Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Bonora

Showing results (241-250 of 302) with videos related to

Pageof 31
Sort By:
Antimicrobial Agents and Chemotherapy|December 28, 2007
Tipranavir (TPV) genotypic inhibitory quotient predicts virological response at 48 weeks to TPV-based salvage regimensDaniel Gonzalez de Requena, Stefano Bonora, Andrea Calcagno, et al.
Frontiers in Microbiology|November 20, 2025
The cerebrospinal fluid virome in people with HIV: links to neuroinflammation and cognitionMattia Trunfio, Rossana Scutari, Valeria Fox, et al.
European Heart Journal|January 22, 2013
Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy eraEnrico Cerrato, Fabrizio D'Ascenzo, Giuseppe Biondi-Zoccai, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 22, 2019
In-hospital and long-term outcomes of HIV-positive patients undergoing PCI according to kind of stent: a meta-analysisMattia Peyracchia, Roberto Verardi, Sergio Raposeiras Rubin, et al.
Pharmaceuticals (Basel, Switzerland)|June 28, 2023
A Novel UHPLC-MS/MS Method for the Quantification of Seven Opioids in Different Human TissuesAlessandra Manca, Amedeo De Nicolò, Elisa Delia De Vivo, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2026
The plasma and intracellular exposure of intramuscularly administered long-acting cabotegravir and rilpivirine in people with HIVMicol Ferrara, Viviana Maccario, Federica Barrera, et al.
Journal of Medical Virology|January 26, 2011
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapyNicola Gianotti, Laura Galli, Maurizio Zazzi, et al.
The Journal of Antimicrobial Chemotherapy|November 23, 2019
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trialLaura Dickinson, Rohan Gurjar, Wolfgang Stöhr, et al.
The Journal of Infectious Diseases|June 2, 2011
Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunctionSudeep P Pushpakom, Neill J Liptrott, Sonia Rodríguez-Nóvoa, et al.
Antiviral Therapy|September 9, 2011
Effect of raltegravir on the total and unintegrated proviral HIV DNA during raltegravir-based HAARTEmanuele Nicastri, Chiara Tommasi, Isabella Abbate, et al.
Pageof 31

Showing results (241-250 of 302) with videos related to

Sort By:
Pageof 31
Antimicrobial Agents and Chemotherapy|December 28, 2007
Tipranavir (TPV) genotypic inhibitory quotient predicts virological response at 48 weeks to TPV-based salvage regimensDaniel Gonzalez de Requena, Stefano Bonora, Andrea Calcagno, et al.
Frontiers in Microbiology|November 20, 2025
The cerebrospinal fluid virome in people with HIV: links to neuroinflammation and cognitionMattia Trunfio, Rossana Scutari, Valeria Fox, et al.
European Heart Journal|January 22, 2013
Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy eraEnrico Cerrato, Fabrizio D'Ascenzo, Giuseppe Biondi-Zoccai, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 22, 2019
In-hospital and long-term outcomes of HIV-positive patients undergoing PCI according to kind of stent: a meta-analysisMattia Peyracchia, Roberto Verardi, Sergio Raposeiras Rubin, et al.
Pharmaceuticals (Basel, Switzerland)|June 28, 2023
A Novel UHPLC-MS/MS Method for the Quantification of Seven Opioids in Different Human TissuesAlessandra Manca, Amedeo De Nicolò, Elisa Delia De Vivo, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2026
The plasma and intracellular exposure of intramuscularly administered long-acting cabotegravir and rilpivirine in people with HIVMicol Ferrara, Viviana Maccario, Federica Barrera, et al.
Journal of Medical Virology|January 26, 2011
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapyNicola Gianotti, Laura Galli, Maurizio Zazzi, et al.
The Journal of Antimicrobial Chemotherapy|November 23, 2019
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trialLaura Dickinson, Rohan Gurjar, Wolfgang Stöhr, et al.
The Journal of Infectious Diseases|June 2, 2011
Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunctionSudeep P Pushpakom, Neill J Liptrott, Sonia Rodríguez-Nóvoa, et al.
Antiviral Therapy|September 9, 2011
Effect of raltegravir on the total and unintegrated proviral HIV DNA during raltegravir-based HAARTEmanuele Nicastri, Chiara Tommasi, Isabella Abbate, et al.
Pageof 31